Index Entries

Richard Urso
May 15, 2022

Dr. Urso is a former Director of Orbital Oncology at MD Anderson Cancer Center.

“What is the distribution of this product, this messenger RNA, this lipid nanoparticle? Well, guess what? It distributes everywhere… The lipid nonparticle does not stay in the arm. In fact, we now know that a large part of it goes into the lymph node, still making spike protein 60 days later…

They never told people that, ‘Hey, we’re going to stick it in your arm, it’s going to show up in your lymph nodes, it’s going to show up in your brain, your ovaries, your bone marrow, your adrenal glands, your liver, your spleen, which is then going to track up your Vegas nerve and go to your basal ganglia. All these things are happening. How do I know? Because the studies have been done now…

These studies are done. I’m not giving you opinions, I’m just giving you data. So it goes everywhere, it’s blocking important tumor-repair genes called P53. It’s blocking bracha. It’s also messing with micro-RNA 27A which causes upticks in colon-cancer cells… It’s messing with toll-like receptors 7 and 8, which (are important for) immune surveillane, for viruses, so we’ll see a huge uptick in viruses that lay kind of dormant in our body, like the herpes virus family.”

video
adverse events,cancer,COVID-19,mRNA,vaccine biodistribution,vaccine dynamics,vaccines